Fic Capital Inc sold 1,299 shares as Biogen Idec Inc (BIIB)’s stock declined 13.45%. The Fic Capital Inc holds 6,233 …
On August 16, 2017 the stock rating was set at “Conviction Buy” according to a Goldman Sachs report which is up from …
A 2.78% percent loss this year for shares of Biogen Inc. (BIIB ) was accompanied by overwhelming institutional selling, thus leading this stock to underperform. But …
Health sector funds also often hold bio-technology stocks like Gilead Sciences (GILD) or Biogen (BIIB). Health care stocks are considered ... The satellite …
Alexion Pharmaceuticals (ALXN - Free Report) got a boost with the EU approving its key revenue driver Soliris for an additional indication. Meanwhile, Biogen (BIIB - Free Report) was in the news with an investigation being launched into …
ZACKS1mon
For more than three years, Biogen stock has had a strong consolidation zone between $250 and $300 per share. Within it, $280 stands out as a shorter-term pivot point. Recently, the bulls broke out from it to rally 15%. Now I look to it to act …
The Biogen Inc. (Nasdaq: BIIB) stock price was down about 6% this morning (Friday) after the company missed on Q1 earnings – but this slip won't last… Biogen reported earnings per share (EPS) of $3.82 compared to estimates of $3.91. …
Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)‘s announcement that it has once again failed in its quest to prove solanezumab to be a viable treatment for Alzheimer’s patients. While trading …
The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …